PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, giving promising advancements across several healthcare and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, much more trustworthy alternate for therapeutic u